A Phase I Study of Three Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons With CD4+ Cell Number > 300 Cells/mm3

An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3)

NCT00000649 ·Status: COMPLETED ·Phase: PHASE1

Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women

NCT00592124 ·Status: COMPLETED ·Phase: PHASE2

Single-Dose Study of MK-4250 Monotherapy in Anti-Retroviral Therapy-Naive, Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-4250-002)

NCT03351699 ·Status: COMPLETED ·Phase: PHASE1

Safety and Pharmacokinetics of Oral Islatravir (MK-8591) Once Monthly in Participants at Low Risk of Human Immunodeficiency Virus 1 (HIV-1) Infection (MK-8591-016)

NCT04003103 ·Status: COMPLETED ·Phase: PHASE2

A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults

NCT00242879 ·Status: TERMINATED ·Phase: PHASE2

A Study of Viracept in HIV-Positive Women

NCT00002171 ·Status: COMPLETED ·Phase: PHASE2

Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*

NCT00511368 ·Status: COMPLETED ·Phase: PHASE2

A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

NCT00002440 ·Status: COMPLETED ·Phase: PHASE2

Activity of MK-8504 in Anti-retroviral-naïve, Human Immunodeficiency Virus 1 (HIV-1) Infected Participants (MK-8504-002)

NCT03188523 ·Status: COMPLETED ·Phase: PHASE1

The Safety and Effectiveness of PMPA Prodrug in HIV-Infected Patients

NCT00002396 ·Status: UNKNOWN ·Phase: PHASE1

Biktarvy for Non-Occupational Post-Exposure Prophylaxis (nPEP)

NCT03499483 ·Status: COMPLETED ·Phase: PHASE4

Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)

NCT00002079 ·Status: COMPLETED ·Phase: PHASE2

To Investigate the Safety and Efficacy of UB-421 Monotherapy in HIV Infected Adults

NCT02369146 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients

NCT00002390 ·Status: COMPLETED ·Phase: PHASE2

Safety and Biological Activity of Vesatolimod in HIV-1 Infected, Virologically Suppressed Adults

NCT02858401 ·Status: COMPLETED ·Phase: PHASE1

3BNC117-LS and 10-1074-LS in Viremic HIV-infected Individuals

NCT04250636 ·Status: COMPLETED ·Phase: PHASE1

A Compassionate Use Study of Tenofovir Disoproxil Fumarate as Treatment for HIV Infection

NCT00002453 ·Status: COMPLETED ·Phase: NA

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3

NCT00002161 ·Status: COMPLETED ·Phase: NA

An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.

NCT00081588 ·Status: COMPLETED ·Phase: PHASE2

Multiple Dose BE Study With Nevirapine 400mg PR Tablets

NCT02202005 ·Status: COMPLETED ·Phase: PHASE1

HIV Non Occupational Post-Exposure Prophylaxis (PEP)

NCT00594646 ·Status: COMPLETED ·Phase: PHASE4

A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy

NCT01026727 ·Status: TERMINATED ·Phase: PHASE2

The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors

NCT00002213 ·Status: COMPLETED ·Phase: PHASE2

The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine

NCT00002381 ·Status: COMPLETED ·Phase: PHASE1

Phase I Study of the Safety, Tolerance, and Pharmacokinetics of 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA; Adefovir Dipivoxil) in HIV-Infected Patients

NCT00002128 ·Status: COMPLETED ·Phase: PHASE1